TherapeuticsMD, Inc.

TXMD · Nasdaq · SIC 2834: Pharmaceutical Preparations
370
SEC Filings

Business Summary

TherapeuticsMD, Inc. is a pharmaceutical royalty company that transitioned from a women's healthcare company in December 2022. It licenses products including IMVEXXY, BIJUVA, ANNOVERA, and prescription prenatal vitamins (BocaGreenMD, vitaMedMD brands) to Mayne Pharma for U.S. commercialization, and to Knight Therapeutics and Theramex for international markets. Revenue is primarily derived from royalties and milestone payments under these licensing agreements.

Next Earnings

Q2 FY2026 — expected 2026-08-12

Key Facts from Earnings Calls

TypeSubjectDetailQuarter
topic_mentionTXMDdiscussed_in_filing Cybersecurity
topic_mentionTXMDdiscussed_in_filing Trusted Computing
topic_mentionTXMDdiscussed_in_filing Blockchain & Crypto
topic_mentionTXMDdiscussed_in_filing Supply Chain
topic_mentionTXMDdiscussed_in_filing Regulation
topic_mentionTXMDdiscussed_in_filing Healthcare & Bio
topic_mentionTXMDdiscussed_in_filing Sovereign & Government
topic_mentionTXMDdiscussed_in_filing Cybersecurity
topic_mentionTXMDdiscussed_in_filing Trusted Computing
topic_mentionTXMDdiscussed_in_filing Blockchain & Crypto
topic_mentionTXMDdiscussed_in_filing Supply Chain
topic_mentionTXMDdiscussed_in_filing Regulation
topic_mentionTXMDdiscussed_in_filing Healthcare & Bio
topic_mentionTXMDdiscussed_in_filing Sovereign & Government
topic_mentionTXMDdiscussed_in_filing Cybersecurity
topic_mentionTXMDdiscussed_in_filing Trusted Computing
topic_mentionTXMDdiscussed_in_filing Blockchain & Crypto
topic_mentionTXMDdiscussed_in_filing Supply Chain
topic_mentionTXMDdiscussed_in_filing Regulation
topic_mentionTXMDdiscussed_in_filing Healthcare & Bio

Annual Reports (10-K)

FiledPeriodAccessionSourceFull Text
2026-03-302025-12-310001213900-26-036515EDGAR68K words
2025-03-272024-12-310001013762-25-003442EDGAR—
2024-03-292023-12-310001213900-24-028003EDGAR—
2023-04-072022-12-310001564590-23-005514EDGAR—
2022-03-232021-12-310001564590-22-011525EDGAR—
2021-03-042020-12-310001387131-21-003140EDGAR—
2020-02-242019-12-310001387131-20-002086EDGAR—
2019-02-272018-12-310001387131-19-001471EDGAR—
2018-02-232017-12-310001387131-18-000776EDGAR—
2017-02-282016-12-310001387131-17-001111EDGAR—

Quarterly Reports (10-Q)

FiledPeriodAccessionSourceFull Text
2025-11-122025-09-300001213900-25-109381EDGAR20K words
2025-08-122025-06-300001213900-25-075003EDGAR—
2025-05-132025-03-310001213900-25-042697EDGAR—
2024-11-122024-09-300001213900-24-096811EDGAR—
2024-08-122024-06-300001213900-24-067771EDGAR—
2024-05-102024-03-310001213900-24-041738EDGAR—
2023-11-142023-09-300001193125-23-277143EDGAR—
2023-08-142023-06-300001193125-23-211458EDGAR—
2023-05-152023-03-310001193125-23-145064EDGAR—
2022-11-142022-09-300001564590-22-037666EDGAR—
2022-08-152022-06-300001564590-22-029490EDGAR—
2022-05-162022-03-310001564590-22-020440EDGAR—

Recent Current Reports (8-K)

FiledAccessionSourceFull Text
2026-03-300001213900-26-036519EDGAR1K words
2026-01-210001213900-26-005779EDGAR—
2025-12-160001213900-25-122240EDGAR—
2025-11-130001213900-25-109479EDGAR—
2025-08-120001213900-25-074975EDGAR—
2025-05-130001213900-25-042663EDGAR—
2025-04-090001213900-25-030089EDGAR—
2025-03-270001013762-25-003407EDGAR—
2024-12-050001213900-24-106095EDGAR—
2024-11-120001213900-24-096804EDGAR—

370 total filings indexed. 338 additional filings (S-1, DEF 14A, etc.) View all (JSON) · SEC EDGAR

Sector Peers

SXTP — 60 DEGREES PHARMACEUTICALS, INC. ABT — ABBOTT LABORATORIES ABEO — ABEONA THERAPEUTICS INC. ABVC — ABVC BIOPHARMA, INC. ACAD — ACADIA PHARMACEUTICALS INC ACTU — ACTUATE THERAPEUTICS, INC. ADCT — ADC Therapeutics SA ADIL — ADIAL PHARMACEUTICALS, INC.

Tags

women's-healthcare pharmaceutical-royalties menopause-treatments prescription-prenatal-vitamins

Company Identity

CIK0000025743
TickerTXMD
ExchangeNasdaq
SIC2834: Pharmaceutical Preparations
IncorporatedNV

Get More Data

This is the free public profile. For structured JSON with full provenance chain, use the API:

JSON Profile Stock Quote AI Readiness Report
Origin Provenance
page leaf: 195e6d940812e92887dd2f71643896b45e32b9adea8f4f019326eff92c58ac28
parent: 75c92af6459a701acf82ac66cd7fe9b226faa2b9e983efceefce1ac3a38a8ad6
content hash: 2ae05905e6c8a4b0e2ebb8c2eafb71d88447a3485ce540c079dece3b90db7a28
signed: 2026-04-13T04:47:56.248Z
sources: 22 verified data leaves
chain: SEC.gov PEM → origin.rootz.global extraction → this page
verify: sha256(content_hash + parent + timestamp) = leaf